MAPK-3 analysis showed a sensitivity of 88, 87, 72, and 88% and specificity of 94, 100, 56, and 99% for diagnosis of BC, BBC, transitional carcinoma, and high grade malignancy respectively. This evidence concerns the gene MAPK3 and breast cancer.